Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study record adds an NIH funding note for 2017 and updates the document version to v3.6.6, while removing the previous v3.6.5 version.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.6.5 was added and Revision: v3.6.4 was removed, signaling a minor update to the page's version or underlying content.SummaryDifference0.1%

- Check44 days agoChange DetectedNo textual changes were captured for this page in the provided data.SummaryDifference0.0%

- Check51 days agoChange DetectedThe study record page was updated to Revision: v3.6.4, indicating a new release of the page. This update appears to be internal maintenance rather than a modification to study content.SummaryDifference0.0%

- Check72 days agoChange DetectedA revision label on the study page was updated from v3.6.2 to v3.6.3, indicating an administrative update to the ClinicalTrials.gov page. It does not alter the study details, enrollment, or eligibility.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now displays revision v3.6.2, replacing the previous v3.6.0. This indicates a page-build update rather than a change to study details.SummaryDifference0.0%

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.